L’Houcine Ouafik

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Fabrice Barlési, Julien Mazières, Jean‐Philippe Merlio et al. · The Lancet · 2016 · 969 citations · Full text

Advanced Lung Disease, Medicine, Pathology +8

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

Philippe Métellus, Béma Coulibaly, Carole Colin et al. · Acta Neuropathologica · 2010 · 286 citations

Neuro-oncology, Somatic Variant, Tumor Heterogeneity +14

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

A. Jeanson, Pascale Tomasini, M. Souquet-Bressand et al. · Journal of Thoracic Oncology · 2019 · 221 citations · Full text

Medicine, Immune Checkpoint Inhibitors, Immunology +7

Expression of somatostatin receptor subtypes in human brain tumors

Anne Dutour, Ujendra Kumar, Rosemarie Panetta et al. · International Journal of Cancer · 1998 · 212 citations

Correlation Between O⁶-Methylguanine-DNA Methyltransferase and Survival in Inoperable Newly Diagnosed Glioblastoma Patients Treated With Neoadjuvant Temozolomide

Olivier Chinot, Maryline Barrié, S. Fuentès et al. · Journal of Clinical Oncology · 2007 · 203 citations · Full text